Get emailed when COLL changes direction
Factor Model (net -1.4)
Factor Model
net -1.4
Est. Revisions
-0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0
Analysis pending — waiting for first signal cycle.
Evidence
5d ago
Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference
yahoo-finance
5d ago
Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference
yahoo-finance
22d ago
Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers
yahoo-finance
Fundamentals & Data ▾
Collegium Pharmaceutical, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
Mkt Cap
$1B
P/E
19.1 fwd 5.2
Beta
0.77
52w Range
$25.86 - $50.79
Short Interest
5.5M 20.4%
Days to Cover
8.4 +20%
Technicals
downtrend
from 52w Hi
-6.7%
1w return
-6.7%
Insiders
selling
0B / 9S
EPS Estimate
$1.63
-0.6% 30d
0up / 1dn
Est. Dispersion
18%
5 analysts
Analyst Target
$54
$44 - $60
Options P/C
0.00
Insider Cluster
strong sell
0B / 8S
Fund Convergence
strong
Renaissance, Citadel, D.E. Shaw, Two Sigma
Financials
Revenue
$205M +13% YoY
FCF
$122M
Gross Margin
62%
Op Margin
30%
Momentum:
decelerating
Top Holders
Renaissance
$75M
Citadel
$6M
D.E. Shaw
$5M
Two Sigma
$2M
Recent Filings & Data
insider trade
68
net selling
· $22,394,923 sold
17 insiders · 68 transactions (30d)
Recent transactions
DIETER DAVID · sell · $488,099
DIETER DAVID · sell · $228,110
DREYER SCOTT · sell · $2,019,437
KARNANI VIKRAM · award
DREYER SCOTT · award
SMITH THOMAS BRAIN M.D. · award
TUPPER COLLEEN · award
DIETER DAVID · award
DREYER SCOTT · sell · $847,855
DREYER SCOTT · exercise · $279,840
BALICE-GORDON RITA J · sell · $171,673
FALLON JOHN A · sell · $1,645,536
FALLON JOHN A · exercise · $432,578
TUPPER COLLEEN · sell · $1,215,753
SMITH THOMAS BRAIN M.D. · sell · $671,576
DREYER SCOTT · sell · $626,171
DREYER SCOTT · exercise · $349,741
SANTINI GINO · sell · $201,018
SANTINI GINO · exercise · $201,750
DREYER SCOTT · sell · $184,881
DREYER SCOTT · exercise · $103,734
RUBRIC CAPITAL MANAGEMENT L.P. · sell · $946,250
FREUND JOHN GORDON · sell · $400,641
FREUND JOHN GORDON · sell · $202,149
FREUND JOHN GORDON · exercise · $201,750
LURKER NANCY S · award
PAYA CARLOS V · award
FALLON JOHN A · award
BALICE-GORDON RITA J · award
SANTINI GINO · award
BOHLIN GAREN G. · award
FREUND JOHN GORDON · award
DREYER SCOTT · sell · $624,794
TUPPER COLLEEN · sell · $228,250
DIETER DAVID · award
DREYER SCOTT · sell · $67,661
TUPPER COLLEEN · sell · $29,313
DREYER SCOTT · sell · $461,672
TUPPER COLLEEN · sell · $313,413
DREYER SCOTT · sell · $169,299
TUPPER COLLEEN · sell · $103,591
KUHLMANN SHIRLEY R. · sell · $2,426,634
KUHLMANN SHIRLEY R. · exercise · $961,200
KUHLMANN SHIRLEY R. · award
DREYER SCOTT · award
SMITH THOMAS BRAIN M.D. · award
TUPPER COLLEEN · award
HEFFERNAN MICHAEL THOMAS · award
LURKER NANCY S · award
KUHLMANN SHIRLEY R. · sell · $908,628
KUHLMANN SHIRLEY R. · exercise · $586,850
KARNANI VIKRAM · award
SMITH THOMAS BRAIN M.D. · sell · $351,320
KUHLMANN SHIRLEY R. · sell · $773,792
KUHLMANN SHIRLEY R. · sell · $814,180
TUPPER COLLEEN · sell · $674,368
DREYER SCOTT · sell · $3,662,548
DREYER SCOTT · exercise · $1,802,250
FALLON JOHN A · award
MCFARLANE NEIL F · award
BALICE-GORDON RITA J · award
SANTINI GINO · award
BOHLIN GAREN G. · award
FREUND JOHN GORDON · award
HEFFERNAN MICHAEL THOMAS · award
MELINCOFF GWEN A · award
BOHLIN GAREN G. · sell · $936,311
BOHLIN GAREN G. · exercise · $166,084
6 signals · latest 5d ago
Get alerted when COLL changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.